Sort

Search

13/08/2024 Personalized Medicine in Acromegaly: The ACROFAST Study
Marques-Pamies, M, Gil, J, Sampedro-Nuñez, M, Valassi, E, Biagetti, B, Giménez-Palop, O, Hernández, M, Martínez, S, Carrato, C, Villar-Taibo, R, Araujo-Castro, M, Blanco, C, Simón-Muela, I, Simó-Servat, A, Xifra, G, Vázquez, F, Pavón, I, Rosado, JA, García-Centeno, R, Zavala, R, Hanzu, FA, Mora, M, Aulinas, A, Vilarrasa, N, Librizzi, S, Calatayud, M, de Miguel, P, Alvarez-Escola, C, Picó, A, Salinas, I, Fajardo-Montañana, C, Cámara, R, Bernabéu, I, Jordà, M, Webb, SM, Marazuela, M, Puig-Domingo, M. Personalized Medicine in Acromegaly: The ACROFAST Study. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2024; 110(1)DOI:10.1210/clinem/dgae444. PMID:38943661. IF:5.100(Q1/2D).
13/08/2024 PTCy vs CNI-based GVHD prophylaxis in HLA-matched transplants for Hodgkin lymphoma: a study of the LWP of the EBMT
Montoro, J, Ngoya, M, Kulagin, A, Giebel, S, Broers, AEC, Bramanti, S, Halahleh, K, Pérez-Simón, JA, Solano, C, Ozcelik, T, Blaise, D, Sanz, J, Henriques, M, de Latour, RP, Martino, R, Scheid, C, Fox, L, Gromek, T, Jurado, M, Sakellari, I, Van Gorkom, G, Matteucci, P, Nagler, A, Koc, Y, Glass, B. PTCy vs CNI-based GVHD prophylaxis in HLA-matched transplants for Hodgkin lymphoma: a study of the LWP of the EBMT. Blood Advances. 2024; 8(15)DOI:10.1182/bloodadvances.2024013328. PMID:38810260. IF:7.100(Q1/2D).
12/08/2024 Prognostic significance of residual tumor at restaging transurethral bladder resection in high-risk non-muscle-invasive bladder cancer
Guigui, A, Basile, G, Zattoni, F, Gallioli, A, Verri, P, Aumatell, J, Gondran-Tellier, B, Lechevallier, E, Bastide, C, Uleri, A, Sica, M, Long-Depaquit, T, Dinoi, G, Moro, FD, Akiki, A, Toledano, H, Rajwa, P, Montorsi, F, Amparore, D, Porpiglia, F, Breda, A, Moschini, M, Baboudjian, M. Prognostic significance of residual tumor at restaging transurethral bladder resection in high-risk non-muscle-invasive bladder cancer. WORLD JOURNAL OF UROLOGY. 2024; 42(1)DOI:10.1007/s00345-024-05192-x. PMID:39133324. IF:2.900(Q2/3D).
12/08/2024 Long-Term Results of Bioresorbable Vascular Scaffolds in Patients With In-Stent Restenosis The RIBS VI Study
Cuesta, J, Pérez-Vizcayno, MJ, del Blanco, BG, Bosa, F, de Prado, AP, Rumoroso, JR, Romaguera, R, Gutiérrez, H, Touchard, AG, López-Minguez, JR, Trillo, R, Hernandez, JMD, Moreno, R, Velázquez, M, Moris, C, Kockar, MJ, Jiménez-Quevedo, P, Bastante, T, del Val, D, Rivero, F, Alfonso, F. Long-Term Results of Bioresorbable Vascular Scaffolds in Patients With In-Stent Restenosis The RIBS VI Study. JACC-Cardiovascular Interventions. 2024; 17(15)DOI:10.1016/j.jcin.2024.05.038. PMID:39142758. IF:11.400(Q1/1D).
12/08/2024 Position Statement on Cardiac Computed Tomography Following Left Atrial Appendage Occlusion
Korsholm, K, Iriart, X, Saw, J, Wang, DD, Berti, S, Galea, R, Freixa, X, Arzamendi, D, De Backer, O, Kramer, A, Cademartiri, F, Cochet, H, Odenstedt, J, Aminian, A, Raeber, L, Cruz-Gonzalez, I, Garot, P, Jensen, JM, Alkhouli, M, Nielsen-Kudsk, JE. Position Statement on Cardiac Computed Tomography Following Left Atrial Appendage Occlusion. JACC-Cardiovascular Interventions. 2024; 17(15)DOI:10.1016/j.jcin.2024.04.050. PMID:39142755. IF:11.400(Q1/1D).
12/08/2024 Early Nonprocedural Bleeding After Left Atrial Appendage Occlusion
Mesnier, J, Cruz-González, I, Guedeney, P, Arzamendi, D, Freixa, X, Nombela-Franco, L, Peral, V, Caneiro-Queija, B, Mangieri, A, Trejo-Velasco, B, Asmarats, L, Cepas-Guillén, P, Salinas, P, Siquier-Padilla, J, Estevez-Loureiro, R, Laricchia, A, O'Hara, G, Montalescot, G, Rodés-Cabau, J. Early Nonprocedural Bleeding After Left Atrial Appendage Occlusion. JACC-Cardiovascular Interventions. 2024; 17(15)DOI:10.1016/j.jcin.2024.05.032. PMID:39023452. IF:11.400(Q1/1D).